Atea Pharmaceuticals, Inc.
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT
Last updated:
Abstract:
The use of described compounds or pharmaceutically acceptable salts or compositions thereof for the treatment of a host infected with an RNA virus other than HCV, or other disorder more fully described herein.
Status:
Application
Type:
Utility
Filling date:
17 Mar 2020
Issue date:
16 Jul 2020